Evidence map›Paper›PMID 29603387›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2018

Genotype-phenotype correlations, dystonia and disease progression in spinocerebellar ataxia type 14.

Viorica Chelban, Sarah Wiethoff, Bjørn K Fabian-Jessing, Nourelhoda A Haridy, Alaa Khan, Stephanie Efthymiou, Esther B E Becker, Emer O'Connor, Joshua Hersheson, Katrina Newland and 9 more

Open access · hybridAbstract read
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Spectrum of Dystonia in Spinocerebellar Ataxia.Tremor and other hyperkinetic movements (New York, N.Y.) · 2026
    Pooled it
  2. Article
  3. Article
  4. Familial SCA14: A case report with review.Experimental and therapeutic medicine · 2026
    Article
  5. Article
  6. Dystonic Tremor as Main Clinical Manifestation of SCA21.Movement disorders clinical practice · 2024
    Article
  7. Article
  8. Tremor in Spinocerebellar Ataxia: A Scoping Review.Tremor and other hyperkinetic movements (New York, N.Y.) · 2024
    Article
  9. Novel mutation in exon11 ofFrontiers in genetics · 2023
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Myoclonus-Ataxia Syndromes: A Diagnostic Approach.Movement disorders clinical practice · 2021
    Review
  17. NGS-based detection of a novel mutation in PRKCG (SCA14) in sporadic adult-onset ataxia plus dystonic tremor.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2020
    Article
  18. Article
  19. Spinocerebellar ataxia: an update.Journal of neurology · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 5 countries.

Viorica ChelbanDepartment of Molecular Neuroscience, University College London, Institute of Neurology, London, UK.
Sarah WiethoffDepartment of Molecular Neuroscience, University College London, Institute of Neurology, London, UK.
Bjørn K Fabian-JessingDepartment of Clinical Genetics, Aalborg University Hospital, Aalborg, Denmark.
Nourelhoda A HaridyDepartment of Molecular Neuroscience, University College London, Institute of Neurology, London, UK.
Alaa KhanDepartment of Molecular Neuroscience, University College London, Institute of Neurology, London, UK.
Stephanie EfthymiouDepartment of Molecular Neuroscience, University College London, Institute of Neurology, London, UK.
Esther B E BeckerDepartment of Physiology, Anatomy and Genetics, University of Oxford, Oxford, UK.
Emer O'ConnorDepartment of Molecular Neuroscience, University College London, Institute of Neurology, London, UK.
Joshua HershesonDepartment of Molecular Neuroscience, University College London, Institute of Neurology, London, UK.
Katrina NewlandDepartment of Molecular Neuroscience, University College London, Institute of Neurology, London, UK.
Allan Thomas HojlandDepartment of Clinical Genetics, Aalborg University Hospital, Aalborg, Denmark.
Pernille A GregersenDepartment of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark.
Suzanne G LindquistDanish Dementia Research Centre, Neurogenetics Clinic, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Michael B PetersenDepartment of Clinical Genetics, Aalborg University Hospital, Aalborg, Denmark.
Jørgen E NielsenDanish Dementia Research Centre, Neurogenetics Clinic, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
Michael NielsenDepartment of Neurology, Aalborg University Hospital, Aalborg, Denmark.
Nicholas W WoodDepartment of Molecular Neuroscience, University College London, Institute of Neurology, London, UK.
Paola GiuntiDeparmtent of Molecular Neuroscience, Ataxia Centre UCL, Institute of Neurology, London, UK.
Henry HouldenDepartment of Molecular Neuroscience, University College London, Institute of Neurology, London, UK.
University College London · GBAalborg University Hospital · DKCopenhagen University Hospital · DKNational Hospital for Neurology and Neurosurgery · GBAarhus University Hospital · DKHertie Institute for Clinical Brain Research · DEUniversity of Oxford · GB

Funding

Department of HealthMedical Research Council G0802760Medical Research Council G1001253Medical Research Council MR/J004758/1Wellcome TrustWellcome Trust WT093205MAWellcome Trust WT104033/Z/14/Z
6 · The paper itself

Abstract

backgroundSpinocerebellar ataxia type 14 is a rare form of autosomal dominant cerebellar ataxia caused by mutations in protein kinase Cγ gene. Clinically, it presents with a slowly progressive, mainly pure cerebellar ataxia.

methodsUsing next generation sequencing, we screened 194 families with autosomal dominant cerebellar ataxia and normal polyglutamine repeats. In-depth phenotyping was performed using validated clinical rating scales neuroimaging and electrophysiological investigations.

resultsWe identified 25 individuals from 13 families carrying pathogenic mutations in protein kinase Cγ gene. A total of 10 unique protein kinase Cγ gene mutations have been confirmed of which 5 are novel and 5 were previously described. Our data suggest that the age at onset is highly variable; disease course is slowly progressive and rarely associated with severe disability. However, one third of patients presented with a complex ataxia comprising severe focal and/or task-induced dystonia, peripheral neuropathy, parkinsonism, myoclonus, and pyramidal syndrome. The most complex phenotype is related to a missense mutation in the catalytic domain in exon 11.

conclusionWe present one of the largest genetically confirmed spinocerebellar ataxia type 14 cohorts contributing novel variants and clinical characterisation. We show that although protein kinase Cγ gene mutations present mainly as slowly progressive pure ataxia, more than a third of cases had a complex phenotype. Overall, our case series extends the phenotype and suggests that protein kinase Cγ gene mutations should be considered in patients with slowly progressive autosomal dominant cerebellar ataxia, particularly when myoclonus, dystonia, or mild cognitive impairment are present in the absence of polyglutamine expansion. © 2018 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.

Indexed as

AdultAgedAge of OnsetChild, PreschoolCohort StudiesCysteineDisease ProgressionDystoniaFamily HealthFemaleGenetic Association StudiesGenetic TestingHumansMagnetic Resonance ImagingMaleMiddle AgedCysteinePeptidespolyglutamineProtein Kinase Cprotein kinase C gammaataxiadystoniageneticsPRKCGSCA14

Identifiers

PMID29603387
PMCPMC6175136
OpenAlexW2794462623

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.